A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice
Abstract Background Although DAAs hold promise to significantly reduce rates of chronic HCV infections, its eradication still requires development of an effective vaccine. Prolonged T cell responses and cross neutralizing antibodies are ideal for vaccination against the infection. We aimed to design...
Main Authors: | Reham M. Dawood, Rehab I. Moustafa, Tawfeek H. Abdelhafez, Reem El-Shenawy, Yasmine El-Abd, Noha G. Bader El Din, Jean Dubuisson, Mostafa K. El Awady |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-019-4571-5 |
Similar Items
-
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
by: El-Shenawy Reem, et al.
Published: (2011-08-01) -
Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen
by: Zhan Na, et al.
Published: (2011-11-01) -
An overview of HCV molecular biology, replication and immune responses
by: Nawaz Zafar, et al.
Published: (2011-04-01) -
Hepatitis C virus vaccine design: focus on the humoral immune response
by: Daniel Sepulveda-Crespo, et al.
Published: (2020-07-01) -
Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
by: Ghada M. Salum, et al.
Published: (2020-09-01)